Trial Outcomes & Findings for A Trial of Telemonitoring in Adults With Heart Failure (NCT NCT01393314)

NCT ID: NCT01393314

Last Updated: 2022-08-10

Results Overview

Median time to combined endpoint to see if/when the participants need to be readmitted to the hospital or visit the ED

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

99 participants

Primary outcome timeframe

Participants were followed for the duration of home care services up to 12 months

Results posted on

2022-08-10

Participant Flow

Participant milestones

Participant milestones
Measure
Honeywell HomMed Telemonitor
TeleCareOhio Monitor (Honeywell HomeMed) system provides in-home medical monitoring for patients with chronic disease such as heart failure.
Usual Care
Usual care which consists of usual home-care with educational package.
Overall Study
STARTED
54
45
Overall Study
COMPLETED
54
45
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Trial of Telemonitoring in Adults With Heart Failure

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Honeywell HomMed Telemonitor
n=54 Participants
TeleCareOhio Monitor (Honeywell HomeMed) system provides in-home medical monitoring for patients with chronic disease such as heart failure; telemonitoring post hospitalization.
Usual Care
n=45 Participants
Usual care which consists of usual home-care with educational package.
Total
n=99 Participants
Total of all reporting groups
Age, Continuous
75 years
STANDARD_DEVIATION 12.1 • n=5 Participants
74.7 years
STANDARD_DEVIATION 11.3 • n=7 Participants
74.85 years
STANDARD_DEVIATION 11.7 • n=5 Participants
Sex: Female, Male
Female
40 Participants
n=5 Participants
27 Participants
n=7 Participants
67 Participants
n=5 Participants
Sex: Female, Male
Male
14 Participants
n=5 Participants
18 Participants
n=7 Participants
32 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
9 Participants
n=5 Participants
12 Participants
n=7 Participants
21 Participants
n=5 Participants
Race (NIH/OMB)
White
45 Participants
n=5 Participants
33 Participants
n=7 Participants
78 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Participants were followed for the duration of home care services up to 12 months

Median time to combined endpoint to see if/when the participants need to be readmitted to the hospital or visit the ED

Outcome measures

Outcome measures
Measure
Honeywell HomMed Telemonitor
n=54 Participants
Honeywell HomMed Telemonitor: telemonitoring post hospitalization
Usual Care
n=45 Participants
This participants receive usual care which consists of usual home-care with educational package.
The Amount of Time Participants Are Readmitted to the Hospital or Visit the Emergency Department (ED).
60 Days
Standard Deviation 3
62 Days
Standard Deviation 8.5

SECONDARY outcome

Timeframe: Participants were followed for the duration of home care services up to 12 months

Health Status, Change in Overall Summary Score minimum: 0 maximum: 100 higher scores=better outcome

Outcome measures

Outcome measures
Measure
Honeywell HomMed Telemonitor
n=54 Participants
Honeywell HomMed Telemonitor: telemonitoring post hospitalization
Usual Care
n=45 Participants
This participants receive usual care which consists of usual home-care with educational package.
Kansas City Cardiomyopathy Questionaire
34.3 score on a scale
Standard Deviation 12.9
28.3 score on a scale
Standard Deviation 16.85

Adverse Events

Honeywell HomMed Telemonitor

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Research Compliance Officer

Case Western Reserve University

Phone: 216-368-0134

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place